CompletedPHASE1, PHASE2NCT04484402

Treatment of Patients With Inflammatory-dystrophic Diseases of the Cornea Using Autologous Stem Cells

Studying Corneal dystrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus
Principal Investigator
Igor Volotovski, Prof
Head of the Lab of Institute of Biophysics and Cell Engineering
Intervention
mesenchymal stem cells(biological)
Enrollment
25 enrolled
Eligibility
18 years · All sexes
Timeline
20162019

Study locations (1)

Collaborators

Belarusian State Medical University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04484402 on ClinicalTrials.gov

Other trials for Corneal dystrophy

Additional recruiting or active studies for the same condition.

See all trials for Corneal dystrophy

← Back to all trials